 |
Previous Article | Next Article 
Volume 17, Number 19,
Issue of October 1, 1997
pp. 7471-7479
Copyright ©1997 Society for Neuroscience
Presynaptic Versus Postsynaptic Localization of µ and Opioid Receptors in Dorsal and Ventral Striatopallidal Pathways
Received April 8, 1997; revised June 26, 1997; accepted July 21, 1997.
M. Foster Olive1, 2,
Benito Anton2,
Paul Micevych3,
Christopher J. Evans2, and
Nigel T. Maidment2
1 Interdepartmental Neuroscience Ph.D. Program and
Departments of 2 Psychiatry and Biobehavioral Sciences and
3 Neurobiology, University of California at Los Angeles,
Los Angeles, California 90024
Parallel studies have demonstrated that enkephalin release from
nerve terminals in the pallidum (globus pallidus and ventral pallidum)
can be modulated by locally applied opioid drugs. To investigate
further the mechanisms underlying these opioid effects, the present
study examined the presynaptic and postsynaptic localization of (DOR1) and µ (MOR1) opioid receptors in the dorsal and ventral striatopallidal enkephalinergic system using fluorescence
immunohistochemistry combined with anterograde and retrograde neuronal
tracing techniques. DOR1 immunostaining patterns revealed primarily a
postsynaptic localization of the receptor in pallidal cell bodies
adjacent to enkephalin- or synaptophysin-positive fiber terminals. MOR1 immunostaining in the pallidum revealed both a presynaptic
localization, as evidenced by punctate staining that co-localized with
enkephalin and synaptophysin, and a postsynaptic localization, as
evidenced by cytoplasmic staining of cells that were adjacent to
enkephalin and synaptophysin immunoreactivities. Injections of the
anterograde tracer Phaseolus vulgaris leucoagglutinin
(PHA-L) or the retrograde tracer Texas Red-conjugated dextran amine
(TRD) into the dorsal and ventral striatum resulted in labeling of
striatopallidal fibers and pallidostriatal cell bodies, respectively.
DOR1 immunostaining in the pallidum co-localized only with TRD and not
PHA-L, whereas pallidal MOR1 immunostaining co-localized with PHA-L and
not TRD. These results suggest that pallidal enkephalin release may be modulated by µ opioid receptors located presynaptically on
striatopallidal enkephalinergic neurons and by opioid receptors
located postsynaptically on pallidostriatal feedback neurons.
Key words:
opioid;
striatum;
nucleus accumbens;
enkephalin;
delta
receptor;
mu receptor;
globus pallidus;
ventral pallidum
This article has been cited by other articles:

|
 |

|
 |
 
M. M. Torregrossa and P. W. Kalivas
Neurotensin in the Ventral Pallidum Increases Extracellular {gamma}-Aminobutyric Acid and Differentially Affects Cue- and Cocaine-Primed Reinstatement
J. Pharmacol. Exp. Ther.,
May 1, 2008;
325(2):
556 - 566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-J. Liang, D.-F. Wu, L.-Q. Yang, V. Hollt, and T. Koch
Interaction of the {micro}-Opioid Receptor with Synaptophysin Influences Receptor Trafficking and Signaling
Mol. Pharmacol.,
January 1, 2007;
71(1):
123 - 131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Pecina, K. S. Smith, and K. C. Berridge
Hedonic Hot Spots in the Brain
Neuroscientist,
December 1, 2006;
12(6):
500 - 511.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Drakenberg, A. Nikoshkov, M. C. Horvath, P. Fagergren, A. Gharibyan, K. Saarelainen, S. Rahman, I. Nylander, G. Bakalkin, J. Rajs, et al.
From the Cover: {micro} Opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers
PNAS,
May 16, 2006;
103(20):
7883 - 7888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Smith and K. C. Berridge
The Ventral Pallidum and Hedonic Reward: Neurochemical Maps of Sucrose "Liking" and Food Intake
J. Neurosci.,
September 21, 2005;
25(38):
8637 - 8649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-C. Tang, K. McFarland, S. Cagle, and P. W. Kalivas
Cocaine-Induced Reinstatement Requires Endogenous Stimulation of {micro}-Opioid Receptors in the Ventral Pallidum
J. Neurosci.,
May 4, 2005;
25(18):
4512 - 4520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Schad, J. B. Justice Jr., and S. G. Holtzman
Endogenous Opioids in Dopaminergic Cell Body Regions Modulate Amphetamine-Induced Increases in Extracellular Dopamine Levels in the Terminal Regions
J. Pharmacol. Exp. Ther.,
March 1, 2002;
300(3):
932 - 938.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. M. Stanford and A. J. Cooper
Presynaptic µ and delta Opioid Receptor Modulation of GABAA IPSCs in the Rat Globus Pallidus In Vitro
J. Neurosci.,
June 15, 1999;
19(12):
4796 - 4803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Olive and N. T. Maidment
Opioid Regulation of Pallidal Enkephalin Release: Bimodal Effects of Locally Administered Mu and Delta Opioid Agonists in Freely Moving Rats
J. Pharmacol. Exp. Ther.,
June 1, 1998;
285(3):
1310 - 1316.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. B. Eckersell, P. Popper, and P. E Micevych
Estrogen-Induced Alteration of µ-Opioid Receptor Immunoreactivity in the Medial Preoptic Nucleus and Medial Amygdala
J. Neurosci.,
May 15, 1998;
18(10):
3967 - 3976.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|